Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality.
Del Galy AS, Marouf A, Raffoux E, Robin M, Michonneau D, Sébert M, Sicre de Fontebrune F, Xhaard A, Lengline E, Itzykson R, Frieri C, Dombret H, Fenaux P, Peffault de Latour R, Adès L, Socié G. Del Galy AS, et al. Among authors: frieri c. Leukemia. 2021 Jan;35(1):225-228. doi: 10.1038/s41375-020-1004-9. Epub 2020 Jul 30. Leukemia. 2021. PMID: 32733010 No abstract available.
Correction to: Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality.
Del Galy AS, Marouf A, Raffoux E, Robin M, Michonneau D, Sébert M, de Fontebrune FS, Xhaard A, Lengline E, Itzykson R, Frieri C, Dombret H, Fenaux P, de Latour RP, Adès L, Socié G. Del Galy AS, et al. Among authors: frieri c. Leukemia. 2021 Mar;35(3):934. doi: 10.1038/s41375-020-01112-1. Leukemia. 2021. PMID: 33564086 No abstract available.
Long-term outcomes and risk factor analysis of steroid-refractory graft versus host disease after hematopoietic stem cell transplantation.
Pagliuca S, Prata PH, Xhaard A, Frieri C, Giannoni L, Sutra Del Galy A, Brignier A, Sicre de Fontbrune F, Michonneau D, Dhedin N, Peffault de Latour R, Socié G, Robin M. Pagliuca S, et al. Among authors: frieri c. Bone Marrow Transplant. 2021 Jan;56(1):38-49. doi: 10.1038/s41409-020-0977-3. Epub 2020 Jun 25. Bone Marrow Transplant. 2021. PMID: 32587336
Life expectancy and burden of late complications after reduced intensity conditioning allogeneic transplantation.
Del Galy AS, Rousseau A, Capes A, Michonneau D, Robin M, de Fontbrune FS, Xhaard A, Frieri C, Adès L, Raffoux E, Himberlin C, Baudet M, Peffault de Latour R, Socié G. Del Galy AS, et al. Among authors: frieri c. Bone Marrow Transplant. 2022 Sep;57(9):1365-1372. doi: 10.1038/s41409-022-01715-5. Epub 2022 Jun 2. Bone Marrow Transplant. 2022. PMID: 35654824
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial.
Risitano AM, Röth A, Soret J, Frieri C, de Fontbrune FS, Marano L, Alashkar F, Benajiba L, Marotta S, Rozenberg I, Milojevic J, End P, Nidamarthy PK, Junge G, Peffault de Latour R. Risitano AM, et al. Among authors: frieri c. Lancet Haematol. 2021 May;8(5):e344-e354. doi: 10.1016/S2352-3026(21)00028-4. Epub 2021 Mar 23. Lancet Haematol. 2021. PMID: 33765419 Clinical Trial.
Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria: a multicenter real-life study.
Debureaux PE, Kulasekararaj AG, Cacace F, Silva BGP, Calado RT, Barone F, Sicre de Fontbrune F, Prata PH, Soret J, Sica M, Notaro R, Scheinberg P, Mallikarjuna V, Gandhi S, Large J, Risitano AM, Peffault de Latour R, Frieri C; Severe Aplastic Anemia Working Party of the European Group for Bone Marrow Transplantation. Debureaux PE, et al. Among authors: frieri c. Bone Marrow Transplant. 2021 Oct;56(10):2600-2602. doi: 10.1038/s41409-021-01372-0. Epub 2021 Jul 5. Bone Marrow Transplant. 2021. PMID: 34226670 No abstract available.
Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT.
Risitano AM, Marotta S, Ricci P, Marano L, Frieri C, Cacace F, Sica M, Kulasekararaj A, Calado RT, Scheinberg P, Notaro R, Peffault de Latour R. Risitano AM, et al. Among authors: frieri c. Front Immunol. 2019 Jun 14;10:1157. doi: 10.3389/fimmu.2019.01157. eCollection 2019. Front Immunol. 2019. PMID: 31258525 Free PMC article. Review.
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy.
Mariotti J, Raiola AM, Evangelista A, Carella AM, Martino M, Patriarca F, Risitano A, Bramanti S, Busca A, Giaccone L, Brunello L, Merla E, Savino L, Loteta B, Console G, Fanin R, Sperotto A, Marano L, Marotta S, Frieri C, Sica S, Chiusolo P, Harbi S, Furst S, Santoro A, Bacigalupo A, Blaise D, Angelucci E, Mavilio D, Castagna L, Bruno B. Mariotti J, et al. Among authors: frieri c. Blood Adv. 2020 Aug 25;4(16):3900-3912. doi: 10.1182/bloodadvances.2020001620. Blood Adv. 2020. PMID: 32813875 Free PMC article.
25 results